Results 121 to 130 of about 389,388 (249)

Root cause analysis of the challenges to sustain effectiveness of clinical pharmacist-driven antimicrobial stewardship in a Chinese Tertiary Hospital. [PDF]

Front Public Health
Zhao Z, Zhou Y, Li C, Xu J, Xu C, Lu H, Gao Y, Yu B, Shi G, Zhao Y, Li Z, Yang F, Ding P.   +12 more
europepmc   +1 more source

What are the experiences of team members involved in root cause analysis? A qualitative study. [PDF]

BMC Health Serv Res, 2023
Willis R, Jones T, Hoiles J, Hibbert PD, Schultz TJ.   +4 more
europepmc   +1 more source

Patient therapy outcome modeling in cancer organoids is improved by cancer‐associated fibroblasts and organoid assembly convolution

Molecular Oncology, EarlyView.
Patient‐derived organoids (PDOs) from pancreatic, colorectal, and gastric cancers were used to evaluate standard and experimental therapies. Incorporating cancer‐associated fibroblasts (CAFs) into organoid cultures improved patient therapy outcome prediction.
Marcin Grochowski, Liudmyla Dolinchuk, Michał Jerzak, Albert Gandurski, Tomasz Grochowski, Weronika Wojtyś, Maciej Zadrożny, Wojciech Kaźmierczak, Małgorzata Lenarcik, Marta Matejak‐Górska, Radosław Samsel, Tomasz Olesiński, Dawid Walerych   +12 more
wiley   +1 more source

The associated factors of root cause analysis of incident reporting in public primary healthcare in Malaysia. [PDF]

Sci Rep
Rani HA, Ismail A, Rahman HIA, Sani NARM.   +3 more
europepmc   +1 more source

Epigenetic heterogeneity and plasticity in therapy‐induced tumor states through single‐cell multi‐omics

Molecular Oncology, EarlyView.
Single‐cell multi‐omics reveals epigenetic heterogeneity across therapy‐adaptive tumor states, including quiescent/dormant, drug‐tolerant persister, and EMT‐like phenotypes. By linking regulatory features with state‐associated biomarkers, these approaches inform biomarker‐guided therapeutic strategies for evolving tumors.
Hee Jung Kim, Hwiyeong Lee, Jin Hong, Daechan Park   +3 more
wiley   +1 more source

Improved bayesian network with graph attention and prior algorithm for aircraft engine fault root cause analysis. [PDF]

Sci Rep
Yuan L, Han G, Dong P.
europepmc   +1 more source

PAK1 activation drives divergent resistance mechanisms to aromatase inhibition and tamoxifen in a luminal: A breast cancer model

Molecular Oncology, EarlyView.
Breast cancer remains a major cause of cancer death in women, frequently developing endocrine therapy resistance. This study demonstrates that upregulated p21‐activated kinase 1 (PAK1) activity drives resistance to tamoxifen and long‐term estrogen deprivation in ER+ breast cancer models.
Luisa Schwarzmüller, Janina Müller, Efstathios‐Iason Vlachavas, Lukas Beumers, Lena Fleischhacker, Sara Burmester, Angelika Wörner, Sabine Karolus, Dominic Helm, Cindy Körner, Stefan Wiemann   +10 more
wiley   +1 more source

Root Cause Analysis for Outbreaks of Carbapenem-Resistant <i>Acinetobacter baumannii</i> and <i>Pseudomonas aeruginosa</i> in a Pediatric Intensive Care Unit: A Retrospective Study. [PDF]

Infect Drug Resist
Peng W, Hao Y, Ding H, Wang Z, Tan K, Tan L.   +5 more
europepmc   +1 more source

Proactive method for identification and handling of patient complaints with root cause analysis in Surabaya Islamic Hospital. [PDF]

J Public Health Res, 2023
Aan Adriansyah A, Setianto B, Lukiyono YT, Wikurendra EA.   +3 more
europepmc   +1 more source

ZW4864‐mediated inhibition of the β‐catenin/BCL9/BCL9L complex reveals therapeutic potential in bladder cancer

Molecular Oncology, EarlyView.
BCL9 and BCL9L drive bladder cancer progression by enhancing β‐catenin signaling, promoting proliferation, migration, invasion, and organoid growth. Genetic depletion of BCL9(L) suppresses malignant phenotypes, while pharmacological disruption of the β‐catenin/BCL9(L) complex with ZW4864 inhibits canonical Wnt signaling and tumor‐associated cellular ...
Roland Kotolloshi, Mandy Berndt‐Paetz, Eileen Lerner, Gregoire Najjar, Anca Azoitei, Krishna Pal Singh, Shailendra Kumar Gupta, Olaf Wolkenhauer, Cagatay Günes, Otmar Huber, Marc‐Oliver Grimm, Daniel Steinbach   +11 more
wiley   +1 more source